<DOC>
	<DOC>NCT01243658</DOC>
	<brief_summary>RCT. Two substudies (clinical and experimental). Main objective of the trial is to examine if oxytocin, compared to placebo shows any additional effect on the therapy achievements (outcome) of patients with borderline personality disorder, who receive an in-patient standard psychotherapy (Dialectical-behavioral-therapy, Marsha Linehan (2006)). Secondary objectives : Investigate if oxytocin compared to placebo enhances social trust and emotion recognition in patients with borderline personality disorder. Comparison of the effects of Oxytocin on patients with BPD and major depression.</brief_summary>
	<brief_title>"The Effects of Oxytocin on Patients With Borderline Personality Disorder"</brief_title>
	<detailed_description />
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Gender: Both, male and female Minimum Age: 18 Years Maximum Age: 50 Years Borderline personality disorder or major depression (clinical control group) Mini Mental Status Test &gt; 27 (capacity to consent) chronic or acute somatic health problems Schizophrenia Bipolar affective disorder pregnancy breast feeding neurological disorder allergy to antidegradants</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Oxytocin</keyword>
	<keyword>BPD</keyword>
	<keyword>Borderline</keyword>
</DOC>